The data shows the number of companies in the biopharmaceutical sector in the UK in 2017, by segment. The biopharmaceutical sector researches and produces pharmaceutical medications which are extracted or semi-synthesized from a biological source. These can include vaccines, antibodies, blood and tissue products and therapeutic proteins. In 2017, there were 552 companies involved in small molecules which is the leading segment in the biopharmaceutical sector. This was followed by advanced therapy medicinal products at 97 companies.
Small molecules | 552 |
Antibodies | 63 |
Therapeutic proteins | 71 |
Advanced therapy medicinal products | 97 |
Vaccines | 36 |
Blood and tissue products | 13 |